Pharmapriser ApS: Financial statements 2023
CVR: 36479868
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharmapriser ApS (CVR 36479868) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 10,263 and a net result of DKK -36,223 compared with DKK 16,678 the year before. That is a decrease of 88.2% compared with the year before. The profit margin was -352.9%. Equity in the 2023 report amounted to DKK -73,984.
- Revenue
- DKK 10,263
- Gross Profit
- DKK -8,366
- Profit/Loss
- DKK -36,223
- Equity
- DKK -73,984
- Total Assets
- DKK 68,989
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 10 t. | -8 t. | -36 t. | -74 t. | - |
| 2022 | 87 t. | 17 t. | 17 t. | 105 t. | - |
| 2021 | 78 t. | 24 t. | 19 t. | -41 t. | - |
| 2020 | 44 t. | -4 t. | -3 t. | -59 t. | - |
| 2019 | 14 t. | 1 t. | 1 t. | -57 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharmapriser ApS has published its annual report for 2022. Revenue came to DKK 87,166, and the net result was DKK 16,678.
About Pharmapriser ApS
Pharmapriser ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2014. The company is registered under the industry Detailhandel med tøj. The company was previously named MAIN COPENHAGEN ApS. The management consists of Christian Frisch and Oscar Thalund-Jørgensen. The company is owned by JF Consolidated ApS. In 2025, the company reported a gross profit of DKK -6,263 and a net result of DKK -8,073 compared with DKK -1,860 the year before. Equity in the 2025 report amounted to DKK 40,067.